Drug Interactions & Safety at AAPP 2027 Annual Meeting
5 sessions on drug interactions & safety · April 4–7, 2027, Louisville, KY. Compare drug interactions & safety at other meetings →
Sunday, April 4
13:20–14:20 · Lecture · Clinical Application Series
Gas Station Drugs and Emerging Illicit Substances
JoAn R. Laes · Robert "Cole" Pueringer
Online course on psychoactive products sold at gas stations, convenience stores and online with little oversight. Covers their pharmacology, dependence and withdrawal risks, psychiatric adverse effects, and how to apply this to patient counseling and treatment planning.
Monday, April 5
13:30–14:30 · Lecture · Clinical Application Series
Mastering Mood Stabilizers: Navigating Interactions and Adverse Effects
An online course on safe use of mood stabilizers, covering clinically important drug interactions, adverse effects, monitoring plans, and patient-centered counseling to support adherence and shared decision-making.
14:50–15:50 · Lecture · Clinical Application Series
Neuropsychiatric Comorbidities of Multiple Sclerosis
Covers how common psychiatric symptoms present in people with multiple sclerosis and reviews the safety and efficacy of pharmacologic options given limited evidence. Focuses on choosing individualized treatment regimens for co-occurring psychiatric symptoms.
Tuesday, April 6
08:00–09:00 · Lecture
Advancing Equity in Acute Agitation Management
Online course on disparities in the pharmacologic management of acute agitation across inpatient psychiatric and emergency settings. Covers how structural factors and implicit bias affect prescribing and the pharmacist's role in standardizing protocols and promoting equitable care.
Emergency & Acute Psychiatry · Diverse & Underserved Populations
13:30–14:30 · Lecture · Clinical Application Series
Antiseizure Medications in Neuropsychiatric Practice: Identifying, Preventing, and Managing Adverse Effects
Online course on the systemic and neuropsychiatric adverse effects of antiseizure medications, covering patient-specific risk factors and strategies to prevent, identify and manage problems. Emphasizes individualized treatment plans to improve safety and adherence.
Lithium & Mood Stabilizers · Medical Comorbidity & C-L Psychiatry
Other topics at this meeting
Practice, Policy & Workforce 5Medical Comorbidity & C-L Psychiatry 5Antipsychotic Prescribing 4Anxiety Disorders 4Collaborative & Integrated Care 4Education & Training 4Schizophrenia & Psychosis 4Deprescribing & Polypharmacy 3Depression 3Measurement-Based Care & Diagnosis 3Pharmacogenomics & Precision Psychiatry 3Child & Adolescent 2